PT - JOURNAL ARTICLE AU - Lei Xie AU - Eli J. Draizen AU - Philip E. Bourne TI - Harnessing Big Data for Systems Pharmacology AID - 10.1101/077115 DP - 2016 Jan 01 TA - bioRxiv PG - 077115 4099 - http://biorxiv.org/content/early/2016/09/23/077115.short 4100 - http://biorxiv.org/content/early/2016/09/23/077115.full AB - Systems pharmacology aims to holistically understand genetic, molecular, cellular, organismal, and environmental mechanisms of drug actions through developing mechanistic or predictive models. Data-driven modeling plays a central role in systems pharmacology, and has already enabled biologists to generate novel hypotheses. However, more is needed. The drug response is associated with genetic/epigenetic variants and environmental factors, is coupled with molecular conformational dynamics, is affected by possible off-targets, is modulated by the complex interplay of biological networks, and is dependent on pharmacokinetics. Thus, in order to gain a comprehensive understanding of drug actions, systems pharmacology requires integration of models across data modalities, methodologies, organismal hierarchies, and species. This imposes a great challenge on model management, integration, and translation. Here, we discuss several upcoming issues in systems pharmacology and potential solutions to them using big data technology. It will allow systems pharmacology modeling to be findable, accessible, interoperable, reusable, reliable, interpretable, and actionable.